US Stocks
/
TriSalus Life Sciences, Inc. Warrant Share Price
TriSalus Life Sciences, Inc. Warrant Share Price

TriSalus Life Sciences, Inc. Warrant Share Price

NASDAQ: TLSIW | Micro Cap
$0.90
+$0.90 (--%) Last updated on 26 Aug, 2026 | 00:44 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

TriSalus Life Sciences, Inc. Warrant Stock Performance

Open
$0.89
Prev. Close
N/A
Circuit Range
N/A
Day Range
$0.89 - $0.89
Year Range
$0.80 - $1.71
Volume
270
Average Traded
$0.89

TriSalus Life Sciences, Inc. Warrant Share Price Chart

$0.89$0.89
L
Show Current Price
H

TriSalus Life Sciences, Inc. Warrant Stock Fundamentals & Key Indicators

Market Cap
$34.11M
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
$45.15B
Return On Equity (TTM)
-895.80%
Profit Margin
-154.35%
Debt to Equity
5.05
Quarterly Earnings Growth YoY
77.73%

TriSalus Life Sciences, Inc. Warrant Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$11.57$13.21$8.90$11.41
Net Profit-$41.27-$9.75$1.54-$9.19
Net Profit Margin-356.70%-73.81%17.30%-80.54%
Income ChangeN/A76.38%115.79%-696.75%

TriSalus Life Sciences, Inc. Warrant Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$18.51$29.43$45.15
Net Profit-$63.60-$33.23-$69.69
Net Profit Margin-343.60%-112.91%-154.35%
Income ChangeN/A47.75%-109.72%

About TriSalus Life Sciences, Inc. Warrant

TriSalus Life Sciences Inc is an oncology-focused medical technology business integrating its delivery technology with standard-of-care therapies and its investigational immunotherapeutic, nelitolimod, a class C Toll-like receptor 9 (TRL9) agonist, for patients with solid tumors. The company developed Pressure-Enabled Drug Delivery (PEDD) to overcome high intratumoral pressure and off-target delivery. Its 510(k) cleared device, the TriNav Infusion System using PEDD technology, is used for interventional radiology procedures including transarterial radioembolization (TARE) and transarterial chemoembolization (TACE) in patients with primary liver cancer or liver metastases. It has one reportable segment and generates revenue from sales of PEDD infusion systems, principally related to TriNav.

TriSalus Life Sciences, Inc. Warrant Historical Returns

MonthOpenCloseChange %
Jun 2026
$0.80
$0.80
-39.85%
Mar 2026
$1.33
$1.33
-22.22%
Jan 2026
$1.17
$1.71
+3.01%
Dec 2025
$1.38
$1.66
-29.36%
Aug 2025
$2.31
$2.35
+14.63%
Jul 2025
$1.29
$2.05
+58.91%
Jun 2025
$1.67
$1.29
-19.38%
May 2025
$1.03
$1.60
+55.34%
Apr 2025
$1.18
$1.03
-14.88%
Mar 2025
$1.51
$1.21
-19.87%
Feb 2025
$1.22
$1.51
+39.81%
Jan 2025
$1.05
$1.08
-1.82%

TLSIW Share Price FAQs

What is TriSalus Life Sciences, Inc. Warrant share price today?

chevron-up
TriSalus Life Sciences, Inc. Warrant share price today is $0.90 as on August 26, 2026 at 12:44 am IST.

What is the 52 week high and 52 week low of TriSalus Life Sciences, Inc. Warrant stock?

chevron-up
The 52 week high of TriSalus Life Sciences, Inc. Warrant stock is $1.71, while the 52 week low is $0.80 as of 26 Aug '26.

What is TLSIW's market capitalisation today?

chevron-up
TLSIW market capitalisation is $34.11M as of October 9, 2026, at 4:48 pm IST.

What is TLSIW's net income for the last quarter?

chevron-up
TLSIW's net income for the last quarter is -9.19B USD.

What is the 5 year returns of TLSIW?

chevron-up
The 5 year returns of TLSIW is 9.76% as on 26 Aug '26.

What is the high & low stock price of TLSIW today?

chevron-up
TLSIW stock price hit a high of $0.89 and low of $0.89 as of 26 Aug '26.

Can I buy TLSIW shares in India?

chevron-up
Yes. You can buy TLSIW in India by opening an international trading account.